+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Genotyping Market by Product (Instruments & Services, Reagents & Kits), Technology (Capillary Electrophoresis, Mass Spectrometry, Microarray), Application - Forecast 2024-2030

  • PDF Icon

    Report

  • 187 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5454849
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Genotyping Market size was estimated at USD 20.71 billion in 2023, USD 23.63 billion in 2024, and is expected to grow at a CAGR of 14.14% to reach USD 52.29 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Genotyping Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Genotyping Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Genotyping Market, highlighting leading vendors and their innovative profiles. These include Agena Bioscience, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories Inc., Biofortuna Limited, Danaher Corporation, Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Illumina, Inc., Merck KGaA, PerkinElmer, Inc., Precision Biomarker Resources, Inc., Qiagen NV, Roche Diagnostics Corporation, Sigma-Aldrich Corporation, and ThermoFisher Scientific, Inc.

Market Segmentation & Coverage

This research report categorizes the Genotyping Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Instruments & Services
    • Reagents & Kits
  • Technology
    • Capillary Electrophoresis
    • Mass Spectrometry
    • Microarray
    • PCR
    • Sequencing
  • Application
    • Diagnostics
    • Drug Discovery
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Genotyping Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Genotyping Market?
  3. What are the technology trends and regulatory frameworks in the Genotyping Market?
  4. What is the market share of the leading vendors in the Genotyping Market?
  5. Which modes and strategic moves are suitable for entering the Genotyping Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Genotyping Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing significance of genotyping in drug discovery and development
5.1.1.2. Growing prevalence of genetic diseases such as Parkinson’s, turner syndrome
5.1.1.3. Potential demand for bioinformatics solutions in data analysis
5.1.2. Restraints
5.1.2.1. Relatively expensive equipment
5.1.3. Opportunities
5.1.3.1. Emerging importance of sequencing projects globally
5.1.3.2. Ongoing demand in agriculture industries
5.1.4. Challenges
5.1.4.1. Lack of trained professional and concerns in data management in genotyping
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Genotyping Market, by Product
6.1. Introduction
6.2. Instruments & Services
6.3. Reagents & Kits
7. Genotyping Market, by Technology
7.1. Introduction
7.2. Capillary Electrophoresis
7.3. Mass Spectrometry
7.4. Microarray
7.5. PCR
7.6. Sequencing
8. Genotyping Market, by Application
8.1. Introduction
8.2. Diagnostics
8.3. Drug Discovery
9. Americas Genotyping Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Genotyping Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Genotyping Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Agena Bioscience, Inc.
13.1.2. Agilent Technologies, Inc.
13.1.3. Bio-Rad Laboratories Inc.
13.1.4. Biofortuna Limited
13.1.5. Danaher Corporation
13.1.6. Eurofins Scientific SE
13.1.7. F. Hoffmann-La Roche Ltd.
13.1.8. Illumina, Inc.
13.1.9. Merck KGaA
13.1.10. PerkinElmer, Inc.
13.1.11. Precision Biomarker Resources, Inc.
13.1.12. Qiagen NV
13.1.13. Roche Diagnostics Corporation
13.1.14. Sigma-Aldrich Corporation
13.1.15. ThermoFisher Scientific, Inc.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GENOTYPING MARKET RESEARCH PROCESS
FIGURE 2. GENOTYPING MARKET SIZE, 2023 VS 2030
FIGURE 3. GENOTYPING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GENOTYPING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GENOTYPING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GENOTYPING MARKET DYNAMICS
FIGURE 7. GENOTYPING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GENOTYPING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 10. GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GENOTYPING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. GENOTYPING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS GENOTYPING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS GENOTYPING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES GENOTYPING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES GENOTYPING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC GENOTYPING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC GENOTYPING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. GENOTYPING MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. GENOTYPING MARKET SHARE, BY KEY PLAYER, 2023

Companies Mentioned

  • Agena Bioscience, Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories Inc.
  • Biofortuna Limited
  • Danaher Corporation
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • Merck KGaA
  • PerkinElmer, Inc.
  • Precision Biomarker Resources, Inc.
  • Qiagen NV
  • Roche Diagnostics Corporation
  • Sigma-Aldrich Corporation
  • ThermoFisher Scientific, Inc.

Methodology

Loading
LOADING...

Table Information